دورية أكاديمية

Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

التفاصيل البيبلوغرافية
العنوان: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
المؤلفون: Ramanathan, Ramesh K., Von Hoff, Daniel D.Aff1, Eskens, Ferry, Blumenschein, Jr., George, Richards, Donald, Genvresse, Isabelle, Reschke, Susanne, Granvil, Camille, Skubala, Adam, Peña, Carol, Mross, Klaus
المصدر: Targeted Oncology. 15(2):163-174
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17762596
1776260X
DOI:10.1007/s11523-020-00714-0